Skip to content

13F-HR filed by Allostery Investments LP

Allostery Investments LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 40 holding rows worth $95,734,776.

Accession
0001013594-25-000290
Filed
2025-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 40 entries on the cover page, a total value of $95,734,776 stated on the cover page (in dollars after the unit check, H1), rows summing to $95,734,775 with VALUE read as dollars as filed, 13F file number 028-25258. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPDR SER TR78464A870S&P BIOTECH175,000$15,760,500dollars as filedcall
INVESCO QQQ TR46090E103COM25,000$12,780,750dollars as filedput
ISHARES TR46428743220 YR TR BD ETF100,000$8,733,000dollars as filedput
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS284,517$4,765,660dollars as filed
EVOLUS INC30052C107COM431,117$4,759,532dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock100,000$4,530,000dollars as filed
ABIVAX SA-00370M103SPONSORED ADS591,253$4,327,972dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM479,100$4,057,977dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK1,515,126$3,787,815dollars as filed
ALKERMES PLCG01767105SHS120,000$3,451,200dollars as filed
CYTOKINETICS INC23282W605COM NEW65,000$3,057,600dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock35,000$2,684,150dollars as filed
APELLIS PHARMACEUTICALS INC03753U106COM80,000$2,552,800dollars as filedcall
IONIS PHARMACEUTICALS INC COM462222100Stock65,000$2,272,400dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock75,000$2,257,500dollars as filedcall
AEROVATE THERAPEUTICS INC008064107COM850,684$2,254,313dollars as filed
NOVAVAX INC670002401COM NEW150,000$1,206,000dollars as filedput
XENON PHARMACEUTICALS INC COM98420N105Stock30,000$1,176,000dollars as filed
CONTEXT THERAPEUTICS INC21077P108COM950,166$997,674dollars as filed
MERUS N VN5749R100COM21,735$913,957dollars as filed
MIND MEDICINE MINDMED INC60255C885COM NEW130,000$904,800dollars as filed
RALLYBIO CORP75120L100COM803,398$771,262dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK13,600$753,032dollars as filed
INSMED INC COM PAR $.01457669307Stock10,000$690,400dollars as filed
ANAPTYSBIO INC032724106COM50,000$662,000dollars as filedcall
GOSSAMER BIO INC COM38341P102Stock613,028$554,545dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM25,000$545,000dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK73,314$544,723dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM90,000$524,700dollars as filedcall
CRINETICS PHARMACEUTICALS INC COM22663K107Stock9,700$495,961dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW22,000$470,360dollars as filed
BIOMX INC09090D301COM643,833$470,062dollars as filed
CLIMB BIO INC28658R106COMMON STOCK244,988$440,978dollars as filed
ELEDON PHARMACEUTICALS INC28617k101COM100,000$412,000dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock20,000$387,800dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK100,000$250,000dollars as filedcall
ELEVATION ONCOLOGY INC COM28623U101Stock432,206$243,159dollars as filed
PROMIS NEUROSCIENCES INC74346M406COM NEW195,111$184,926dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM3,600$69,012dollars as filedput
LEXEO THERAPEUTICS INC52886X107COMMON STOCK5,054$33,255dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001013594-25-000290this filing2025-02-14acceptance time not in the bulk data set